Horm Metab Res
DOI: 10.1055/a-2826-9576
Review

Unraveling the Origins of Thyroid Nodules: Inflammation, Hormones, Toxins, and Micronutrient Interactions

Authors

  • Angela D Mazza

    1   Endocrinology, Metabolic Center for Wellness, Oviedo, United States

Thyroid nodules are among the most frequently encountered endocrine abnormalities, affecting up to two-thirds of adults in iodine-sufficient regions. Although thyroid-stimulating hormone (TSH) and genetic mutations have long been implicated in their pathogenesis, emerging evidence reveals a multifactorial interplay between inflammatory, hormonal, toxic, and micronutrient influences that extend beyond the classical model. This narrative review examines the converging biological pathways that contribute to thyroid nodule formation, emphasizing the integrative roles of inflammation, estrogen signaling, environmental endocrine disruptors, and micronutrient imbalance in altering thyroid cellular homeostasis. Chronic low-grade inflammation and oxidative stress create a permissive microenvironment for thyrocyte proliferation and clonal expansion. Estrogen receptor activation—amplified by insulin and IGF-1 signaling—enhances vascular and proliferative responses within thyroid tissue, contributing to the female predominance of nodular disease. Exposure to heavy metals and xenoestrogens disrupts thyroid peroxidase activity, deiodinase regulation, and immune tolerance, while deviations in iodine, selenium, zinc, and vitamin D status further impair redox balance and DNA repair mechanisms. Together, these factors promote a spectrum of structural changes ranging from microscopic hyperplasia to clinically significant nodules. Thyroid nodules represent a visible manifestation of intersecting metabolic and environmental stressors rather than a single endocrine defect. Integrating insights from molecular endocrinology, environmental toxicology, and nutritional science may advance early detection and preventive strategies targeting the inflammatory-hormonal-toxic axis of thyroid disease.



Publication History

Received: 01 February 2026

Accepted after revision: 03 March 2026

Accepted Manuscript online:
03 March 2026

© . Thieme. All rights reserved.

Georg Thieme Verlag KG
Oswald-Hesse-Straße 50, 70469 Stuttgart, Germany